The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...

Marama Labs' CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and ...

Researchers led by the University of Waterloo have discovered how to turn common bacteria into high-efficiency factories ...

Combining mRNA with a specialised lipid nanoparticle could reach areas of the lungs previously inaccessible to conventional ...

In a study published in Nature Communications, researchers from Nanjing University present a novel nanovaccine cocktail formulated by individual conjugation of antigen p210 and adjuvant CpG ODNs onto ...

A collaborative effort between The Wistar Institute, University of Pennsylvania, and INOVIO Pharmaceuticals has led to an ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian ...

The global lipid nanoparticles market, valued at US$ 820.51 million in 2023, is projected to experience significant growth, with an expected market valuation of US$ 2,387.98 million by 2032. This ...

The FDA has granted approval for the IND application of Everest Medicines’ tumour-associated antigen (TAA) vaccine, EVM14.

A vaccine was first approved for prostate cancer ... specific antigens for an enhanced immune response by making lipid ...

Some of these therapies include nanoparticles, such as metal-based ones. In a bioprocess based on the fungus Fusarium oxysporum, Reyad M. El-Sharkawy, PhD, a microbiologist at Benha University in ...